New cream challenges gold standard for skin discoloration
NCT ID NCT05119413
Summary
This study tested if a new skin cream could work as well as the current best treatment for melasma, a condition that causes dark patches on the skin. The new cream replaces a key ingredient (hydroquinone) that can cause side effects with a potentially safer alternative (thiamidol). Forty adults with melasma participated in this blinded study to see which cream was more effective and better tolerated.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Nice
Nice, Alpes-maritimes, 06200, France
Conditions
Explore the condition pages connected to this study.